Chevy Chase Trust Holdings LLC Has $44.25 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Chevy Chase Trust Holdings LLC cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 456,001 shares of the company’s stock after selling 8,015 shares during the period. Chevy Chase Trust Holdings LLC owned approximately 0.06% of Colgate-Palmolive worth $44,250,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CL. Vanguard Group Inc. increased its position in shares of Colgate-Palmolive by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock valued at $6,368,378,000 after acquiring an additional 416,853 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Colgate-Palmolive by 27.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after buying an additional 8,933,912 shares during the last quarter. Norges Bank acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd grew its position in shares of Colgate-Palmolive by 4.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after purchasing an additional 278,150 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Colgate-Palmolive by 1.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,426,430 shares of the company’s stock valued at $352,824,000 after purchasing an additional 77,679 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the sale, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The disclosure for this sale can be found here. Insiders sold a total of 41,177 shares of company stock worth $4,245,835 in the last quarter. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Stock Performance

CL stock traded up $0.53 during midday trading on Wednesday, reaching $103.59. 1,278,749 shares of the company were exchanged, compared to its average volume of 4,368,066. Colgate-Palmolive has a one year low of $67.62 and a one year high of $104.15. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.28. The firm has a market capitalization of $84.99 billion, a price-to-earnings ratio of 32.61, a price-to-earnings-growth ratio of 3.54 and a beta of 0.39. The business has a 50-day moving average price of $98.63 and a two-hundred day moving average price of $92.54.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm’s revenue was up 4.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.77 earnings per share. Equities research analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 1.93%. Colgate-Palmolive’s payout ratio is 63.29%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CL. BNP Paribas began coverage on Colgate-Palmolive in a research note on Monday, June 24th. They issued an “outperform” rating and a $109.00 price target for the company. Bank of America upped their target price on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Royal Bank of Canada increased their price objective on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a report on Monday, April 29th. Citigroup lifted their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Eight investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.